Supplementary Table 2.
Description of patients with adverse events
| Center | Random number | Group | Age | Gender | Adverse event | Day after operation | Severity | Outcome | Instruments treatments | Quit the test |
|---|---|---|---|---|---|---|---|---|---|---|
| 01 | 053 | Control | 77 | Male | MI | 70 | Severe | Death | No | Yes |
| 01 | 129 | Trial | 76 | Male | Intestinal obstruction (postcolon cancer operation) | 68 | Severe | Death | No | Yes |
| 04 | 048 | Trial | 79 | Male | Hepatocellular carcinoma | 162 | Severe | Death | No | Yes |
| 05 | 052 | Control | 81 | Male | MI | 60 | Severe | Death | No | Yes |
| 09 | 038 | Trial | 63 | Male | HF and acute renal insufficiency | 95 | severe | Death | No | Yes |
| 10 | 133 | Trial | 76 | Male | Nasopharyngeal carcinoma | 126 | Severe | Death | No | Yes |
| 14 | 115 | Control | 76 | Male | HF | 75 | Severe | Death | No | Yes |
Center - 01: The Second Affiliated Hospital of Zhejiang University School of Medicine; 04: The First Affiliated Hospital of Lanzhou University; 05: The First Affiliated Hospital of Xi’an Jiaotong University; 10: The First Affiliated hospital of Kunming Medical University; 14: Tianjin Chest Hospital. MI: Myocardial infarction; HF: Heart failure.